WikiMD is world's largest health encyclopedia with
28,547 pages, 3,991,426 edits & 34,308,805 views.
Acalabrutinib and breast feeding
No information is available on the clinical use of acalabrutinib during breastfeeding. Because acalabrutinib is over 97% bound to plasma proteins, and the half-life of the drug and metabolite are less than 7 hours, the amount in milk is likely to be low. However, the protein binding of the active metabolite is not known and the manufacturer recommends that breastfeeding be discontinued during acalabrutinib therapy and for at least 2 weeks after the final dose.
Latest research
Up to date info
Alternative drugs - Acalabrutinib and breast feeding
Suggested alternatives on Acalabrutinib and breast feeding, when available and appropriate.
Breast feeding and drugs
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
External links
WikiMD needs you!
This WikiMD article Acalabrutinib and breast feeding is a stub.
If you are a healthcare professional familiar with the topic Acalabrutinib and breast feeding, or
A subject matter expert or authority on Acalabrutinib and breast feeding, you can help us.
About | Mission | Paid editors welcome!
| Acalabrutinib and breast feeding is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever! |
|---|
| Medicine: Health - Encyclopedia - Topics - Diseases - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers |
 Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |
